New Technology Promises Nonsurgical Cataract Treatment
A new technology is on its way to being available as a non-surgical treatment for cataract. The Janssen Pharmaceuticals has just been recently licensed by the University of Massachusetts Amherst to develop a new treatment that holds promise of revolutionizing procedures for cataracts and presbyopia. It is based on early phase discoveries by physicist Murugappan Muthukumar and Ben Mohr that focuses on the fundamental science of proteins in the lens of the human eye.
Muthukumar, a distinguished professor in Polymer Science and Engineering, and a lifelong eye enthusiast, has done extensive study and understanding of vision. He specializes in the lens of the human eye, its structure and functions. He explains the formation of cataract as an aggregation or clumping of the molecules that make up the lens, which then results in the undesirable scattering of light, the Eurekalert reports.
"I wanted to understand how this aggregation takes place, because if I understand it, I can come up with an approach to correct it," Muthukumar adds. In a related way, treating presbyopia all depends on understanding the origin and nature of cataract. So if the new technology offers a treatment for cataract, it can be used for treating presbyopia as well, the Medical Xpress reports.
In their early phase experiments, Muthukumar and colleagues deliver light into protein solutions hundreds of times, and measure how much came out and at what angle. These measurements provide a simplified model of how molecules are arranged in the human lens.The company's announcement of this long-term collaboration with UMass Amherst, which is one of 15 new healthcare research partnerships revealed to the public this month, has Janssen Pharmaceuticals saying that these age-related eye conditions represent "an area of high unmet need" that will benefit from the company's pursuit of new technology to deliver cutting-edge science.
Bad Cholesterol: Very Low Level Puts You At Risk For Cataract
Researchers have found that a very low level of LDL, or bad cholesterol, increases the risks of cataract. Statins were also found to have no other significant adverse effects except for the visual disorder.
Heart Attack Risk Can Now Be Tested By Gut Bacteria
A new blood test effectiviely diagnoses heart attack risks by identifying the presence of a certain gut bacteria. The test determines the occurrence of heart complications within one month up to seven years.
Diabetes News: Virus Found In Feces Linked To Diabetes Type 1
The latest on diabetes news confirms that virus from feces has been definitively linked to the development of type 1 Diabetes. The study opens up the oppotunity to developm a vaccine to preven the disorder in the near future.
Artificial Intelligence and LED Can Now Diagnose Cataract
Cataract have been proven to be effectively diagnosed by an artificial intelligence system that scans the eye for the disease. Another new technology that effectively detects cataract at a molecular level is LED.
MORE IN ITECHPOST
Is Amazon Censoring Coronavirus Information? Elon Musk Thinks So And He Wants To Shut Them Down
Amazon recently censored a coronavirus skeptic's book on their store temporarily. Elon Musk in a recent Twitter post disagrees with how they handle things and wants them to shut down.
Ancient Maya Civilization: Newly Discovered Artificial Plateau Challenges Traditional Archaeological Beliefs
Scientists have recently discovered new information about ancient Maya civilization breaking the traditional archaeological belief.
Leak Shows That A Red Dead Redemption Remake Is Coming To The PlayStation 5 and Xbox Series X
An anonymous leak has shown that the next-gen consoles will be getting a remake of the classic Western shooter game Red Dead Redemption. Is John Marston staying?